BLOG

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know

Nov 6, 2023

Minnesota's New Prescription Drug Price Transparency Reporting: What You Need to Know | by: Sumeet Singh, Founder & Chairman | Article Posted: November 6, 2023 | In recent years, the transparency surrounding prescription drug pricing has become a focal point for...

Company News

OptumRX Demands Survey From Network Pharmacies, Creating Big Questions

<img decoding="async" alt="OptumRX Demands Survey From Network Pharmacies, Creating Big Questions" width="1080" height="675" data-srcset="https://pharma.solutions/wp-content/uploads/2022/02/blog-image-980x539.jpg 980w, https://pharma.solutions/wp-content/uploads/2022/02/blog-image-480x264.jpg 480w" data-src="https://pharma.solutions/wp-content/uploads/2022/02/blog-image-1080x675.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1080px, 100vw" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" src="https://pharma.solutions/wp-content/uploads/2022/02/blog-image-1080x675.jpg" alt="OptumRX Demands Survey From Network Pharmacies, Creating Big Questions" class="" width="1080" height="675" srcset="https://pharma.solutions/wp-content/uploads/2022/02/blog-image-980x539.jpg 980w, https://pharma.solutions/wp-content/uploads/2022/02/blog-image-480x264.jpg 480w" sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1080px, 100vw" />

OptumRX Demands Survey From Network Pharmacies, Creating Big Questions

May 15, 2017

OptumRX Demands Survey From Network Pharmacies, Creating Big Questions Last week OptumRX released a mandatory survey to a portion of their Network...

OptumRX Demands Survey From Network Pharmacies, Creating Big Questions

<img decoding="async" alt="OptumRX Demands Survey From Network Pharmacies, Creating Big Questions" width="1080" height="675" data-srcset="https://pharma.solutions/wp-content/uploads/2022/02/blog-image-980x539.jpg 980w, https://pharma.solutions/wp-content/uploads/2022/02/blog-image-480x264.jpg 480w" data-src="https://pharma.solutions/wp-content/uploads/2022/02/blog-image-1080x675.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1080px, 100vw" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" src="https://pharma.solutions/wp-content/uploads/2022/02/blog-image-1080x675.jpg" alt="OptumRX Demands Survey From Network Pharmacies, Creating Big Questions" class="" width="1080" height="675" srcset="https://pharma.solutions/wp-content/uploads/2022/02/blog-image-980x539.jpg 980w, https://pharma.solutions/wp-content/uploads/2022/02/blog-image-480x264.jpg 480w" sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1080px, 100vw" />

The NABP Sheds Light on “Cancelled” VAWD Applications

May 1, 2017

The NABP Sheds Light on “Cancelled” VAWD Applications The NABP has clarified that a "Cancelled” application does not equate to a “Denied”...

OptumRX Demands Survey From Network Pharmacies, Creating Big Questions

<img decoding="async" alt="OptumRX Demands Survey From Network Pharmacies, Creating Big Questions" width="1080" height="675" data-srcset="https://pharma.solutions/wp-content/uploads/2022/02/blog-image-980x539.jpg 980w, https://pharma.solutions/wp-content/uploads/2022/02/blog-image-480x264.jpg 480w" data-src="https://pharma.solutions/wp-content/uploads/2022/02/blog-image-1080x675.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1080px, 100vw" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" src="https://pharma.solutions/wp-content/uploads/2022/02/blog-image-1080x675.jpg" alt="OptumRX Demands Survey From Network Pharmacies, Creating Big Questions" class="" width="1080" height="675" srcset="https://pharma.solutions/wp-content/uploads/2022/02/blog-image-980x539.jpg 980w, https://pharma.solutions/wp-content/uploads/2022/02/blog-image-480x264.jpg 480w" sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1080px, 100vw" />

Five Rivers to Move HQ to Philadelphia

Apr 18, 2017

Five Rivers to Move HQ to Philadelphia Pharma Solutions has finalized their relocation to Philadelphia. With this tremendous growth in 2016, this...

FDA Authorizes Florida’s Drug Importation Program

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2024/01/Blog-Featured-Images-1600x880-3-100x55.png" alt="FDA Authorizes Florida’s Drug Importation Program" itemprop="image" class="left" />

FDA Authorizes Florida’s Drug Importation Program

January 9, 2024January 10, 2024

FDA Warning on Xylazine: Mitigating Human Risk

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2023/11/Blog-Featured-Images-1600x880-25-100x55.png" alt="FDA Warning on Xylazine: Mitigating Human Risk" itemprop="image" class="left" />

FDA Warning on Xylazine: Mitigating Human Risk

November 6, 2023November 6, 2023

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2023/11/Blog-Featured-Images-1600x880-24-100x55.png" alt="Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know " itemprop="image" class="left" />

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know

November 6, 2023

FDA Authorizes Florida’s Drug Importation Program

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2024/01/Blog-Featured-Images-1600x880-3-100x55.png" alt="FDA Authorizes Florida’s Drug Importation Program" itemprop="image" class="left" />

FDA Authorizes Florida’s Drug Importation Program

January 9, 2024January 10, 2024

FDA Warning on Xylazine: Mitigating Human Risk

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2023/11/Blog-Featured-Images-1600x880-25-100x55.png" alt="FDA Warning on Xylazine: Mitigating Human Risk" itemprop="image" class="left" />

FDA Warning on Xylazine: Mitigating Human Risk

November 6, 2023November 6, 2023

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2023/11/Blog-Featured-Images-1600x880-24-100x55.png" alt="Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know " itemprop="image" class="left" />

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know

November 6, 2023